View Post

UCLA researchers develop synthetic T cells that mimic form, function of human version

In In The News by Barbara Jacoby

By: Brianna Aldrich From: [email protected] Discovery could be a step toward developing treatments for cancer and autoimmune diseases UCLA researchers have developed synthetic T lymphocytes, or T cells, that are near-perfect facsimiles of human T cells. The ability to create the artificial cells could be a key step toward more effective drugs to treat cancer and autoimmune diseases and could lead to …

View Post

How California can break down barriers to breast cancer treatment

In In The News by Barbara Jacoby

Venetia Lai From: ucla.edu UCLA fact sheets recommend changes to help patients and survivors – particularly low-income women – who face serious obstacles to care More than 29,000 women in California will be diagnosed with breast cancer in 2018. Many of them — especially low-income women, who suffer the worst survival rates — will face economic, emotional and structural obstacles …

View Post

Many Breast Cancer Patients Receive More Radiation Therapy Than Needed

In In The News by Barbara Jacoby

By: Liz Szabo From: npr.org When Annie Dennison was diagnosed with breast cancer last year, she readily followed advice from her medical team, agreeing to harsh treatments in the hope of curing her disease. “You’re terrified out of your mind” after a diagnosis of cancer, said Dennison, 55, a retired psychologist from Orange County, Calif. In addition to lumpectomy surgery, …

View Post

Early cancer detection through saliva is real health care reform

In In The News by Barbara Jacoby

By: Joel Strom From: ocregister.com While the public and media focus their attention on stalled health care reform at the public policy level, they overlook real health care reforms that could significantly improve public health, increase access and lower costs. Consider the recent major breakthrough in early cancer detection using saliva. With the exception of advancements for certain cancers, including …

View Post

THE UNDERSTUDIED CONSEQUENCES OF PERIPHERAL NEUROPATHY AFTER CHEMOTHERAPY

In In The News by Barbara Jacoby

In two papers published in the Journal of the National Cancer Institute researchers from UC Davis, UCLA and other institutions have found that peripheral neuropathy, which causes pain, numbness, and tingling in hands and/or feet, can bother early-stage breast cancer patients years after completing chemotherapy. In addition, a systematic literature review found only a handful of studies that tracked long-term …

View Post

Tata Memorial Centre and Navya Create Experience Engine (XE) that “Thinks” like Expert Oncologists

In In The News by Barbara Jacoby

Tata Memorial Centre (TMC), seeing over 50,000 new cancer patients a year, and Navya, a clinical informatics and patient services organization focused on complex decision making, announced Experience Engine (XE), a machine learning solution to structure experiential knowledge relevant for treatment decision making. The learning solution derives a similarity metric for patients who have received similar treatments and predicts treatment …

View Post

Nearly 1 in 12 patients with a common cancer develop a second, unrelated malignancy

In In The News by Barbara Jacoby

By: Kim Irwin From: ucla.edu Reported by: Redington Life Sciences News UCLA researchers have identified the incidence and long-term outcomes of patients who develop second, unrelated cancers, resulting in a data set that they say sheds new light on the way cancer survivors may need to be monitored post-disease. The researchers identified more than 2.1 million patients from the Surveillance, …

View Post

Here are some ways cancer can thwart the new immunotherapy drugs

In In The News by Barbara Jacoby

119By: Laurie McGinley From: washingtonpost.com A new type of cancer drug designed to unleash the immune system is revolutionizing treatment for advanced melanoma, lung cancer and other malignancies. But some patients who initially respond to the therapy relapse, and researchers are anxious to figure out how and why the delayed resistance occurs. “Does the immune system stop working, or does …

View Post

Huge cancer breakthrough

In In The News by Barbara Jacoby

By: Dan Taylor From: morningticker.com An astonishing breakthrough in cancer treatments could lead to tremendous new treatments. There’s been a tremendous breakthrough in cancer research, and it involves the drug permbrolizumba. Sold in the United States as Keytruda, it has shown an amazing ability to fight lung cancer better than chemotherapty, according to a UPI report. Researchers at the University …

Local Dream Team Develops Cancer Treatment That’s Saving Lives

In In The News by Barbara Jacoby

By:: Lisa Sigell From: cbslocal.com This Friday, CBS will air the annual star-studded telethon Stand Up To Cancer, which has raised millions for cancer research. That research has made possible medical discoveries that are saving lives. Health reporter Lisa Sigell shows us one such discovery here in Los Angeles. A dream team of Cal Tech and UCLA scientists and doctors …